Matches in Wikidata for { <http://www.wikidata.org/entity/Q96692190> ?p ?o ?g. }
Showing items 1 to 55 of
55
with 100 items per page.
- Q96692190 description "artículu científicu espublizáu en xunu de 2020" @default.
- Q96692190 description "im Juni 2020 veröffentlichter wissenschaftlicher Artikel" @default.
- Q96692190 description "scientific article published on 26 June 2020" @default.
- Q96692190 description "wetenschappelijk artikel" @default.
- Q96692190 description "наукова стаття, опублікована 26 червня 2020" @default.
- Q96692190 description "գիտական հոդված հրատարակված 2020 թվականի հունիսի 26-ին" @default.
- Q96692190 name "A phase I study of toripalimab, an anti-PD-1 antibody, in patients with refractory malignant solid tumors" @default.
- Q96692190 name "A phase I study of toripalimab, an anti-PD-1 antibody, in patients with refractory malignant solid tumors" @default.
- Q96692190 type Item @default.
- Q96692190 label "A phase I study of toripalimab, an anti-PD-1 antibody, in patients with refractory malignant solid tumors" @default.
- Q96692190 label "A phase I study of toripalimab, an anti-PD-1 antibody, in patients with refractory malignant solid tumors" @default.
- Q96692190 prefLabel "A phase I study of toripalimab, an anti-PD-1 antibody, in patients with refractory malignant solid tumors" @default.
- Q96692190 prefLabel "A phase I study of toripalimab, an anti-PD-1 antibody, in patients with refractory malignant solid tumors" @default.
- Q96692190 P1433 Q96692190-5B92C817-C58A-46A9-9D6D-1C18CD902F54 @default.
- Q96692190 P1476 Q96692190-90BDA771-EC26-49E6-BBAE-0474B2A9BCE6 @default.
- Q96692190 P2093 Q96692190-8D8DC163-7877-4F73-9EB8-90FB80DD528C @default.
- Q96692190 P2093 Q96692190-9B83C300-D533-4EB9-BE73-704DE7FCC0E7 @default.
- Q96692190 P2093 Q96692190-B05FC3D5-A4E7-40D5-BD38-C5CD1ACBB750 @default.
- Q96692190 P2093 Q96692190-B42BA208-94A6-4C4D-BD81-4B1FA91CC9B7 @default.
- Q96692190 P2093 Q96692190-B75A9351-3E3F-49C3-A153-8A981884137A @default.
- Q96692190 P2093 Q96692190-C96EE08A-8BD9-40EC-90D1-D7374D604A73 @default.
- Q96692190 P2093 Q96692190-CA1A4DB2-82A1-4800-8F1A-1A31739A7762 @default.
- Q96692190 P2093 Q96692190-D614CE38-1F44-4F01-BE43-2100974208AC @default.
- Q96692190 P2093 Q96692190-EB5D5CB5-1627-4798-9D9C-5877ADBB8FA3 @default.
- Q96692190 P2093 Q96692190-EDEDDF9C-0D30-4FB4-B9C6-964BE47BD95A @default.
- Q96692190 P2093 Q96692190-EEF61057-3951-47EA-B821-D5869D134CCD @default.
- Q96692190 P31 Q96692190-EDEC76CE-BA96-47B2-A4DA-E95657FC663B @default.
- Q96692190 P356 Q96692190-076F3A99-16B3-4677-9072-73713D837826 @default.
- Q96692190 P50 Q96692190-6202BDBB-F546-457A-B9F1-E33E198D7F65 @default.
- Q96692190 P50 Q96692190-A7D55470-77A3-4ED2-9BCE-396D870B50D9 @default.
- Q96692190 P577 Q96692190-02C90A68-EA54-46DC-918A-A348C45220DB @default.
- Q96692190 P698 Q96692190-AB7E249C-6E53-4AE0-9BAC-5B5DFEF2595E @default.
- Q96692190 P932 Q96692190-AF015F03-992A-42EA-82F0-3105E1899853 @default.
- Q96692190 P356 CAC2.12068 @default.
- Q96692190 P698 32589350 @default.
- Q96692190 P1433 Q27709712 @default.
- Q96692190 P1476 "A phase I study of toripalimab, an anti-PD-1 antibody, in patients with refractory malignant solid tumors" @default.
- Q96692190 P2093 "Ben-Yan Zou" @default.
- Q96692190 P2093 "Chao Ren" @default.
- Q96692190 P2093 "Dong-Sheng Zhang" @default.
- Q96692190 P2093 "Feng Wang" @default.
- Q96692190 P2093 "Feng-Hua Wang" @default.
- Q96692190 P2093 "Hong-Yun Zhao" @default.
- Q96692190 P2093 "Hui-Yan Luo" @default.
- Q96692190 P2093 "Rui-Hua Xu" @default.
- Q96692190 P2093 "Sheng Yao" @default.
- Q96692190 P2093 "Yang Zhang" @default.
- Q96692190 P2093 "Zhi-Qiang Wang" @default.
- Q96692190 P31 Q13442814 @default.
- Q96692190 P356 "10.1002/CAC2.12068" @default.
- Q96692190 P50 Q87733030 @default.
- Q96692190 P50 Q88037695 @default.
- Q96692190 P577 "2020-06-26T00:00:00Z" @default.
- Q96692190 P698 "32589350" @default.
- Q96692190 P932 "7427305" @default.